BCWORLD PHARM. Co. Ltd Capital Reinvestment Ratio
BCWORLD PHARM. Co. Ltd capital reinvestment ratio. BCWORLD PHARM. Co. Ltd (200780) has a Capital Reinvestment Ratio of 1.14x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.43 Billion) in capital expenditures (₩1.63 Billion). See BCWORLD PHARM. Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BCWORLD PHARM. Co. Ltd (2015–2024)
Capital reinvestment ratio of BCWORLD PHARM. Co. Ltd from 2015 to 2024. This chart tracks BCWORLD PHARM. Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. See 200780 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
BCWORLD PHARM. Co. Ltd Capital Reinvestment Ratio by Year (2015–2024)
BCWORLD PHARM. Co. Ltd capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see BCWORLD PHARM. Co. Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.60x | ₩4.04 Billion | ₩2.41 Billion | ▲ +140.5% |
| 2023 | 0.25x | ₩10.94 Billion | ₩2.71 Billion | ▼ -72.6% |
| 2022 | 0.90x | ₩6.88 Billion | ₩6.22 Billion | ▼ -48.7% |
| 2019 | 1.76x | ₩12.11 Billion | ₩21.32 Billion | ▼ -68.6% |
| 2018 | 5.60x | ₩5.34 Billion | ₩29.92 Billion | ▲ +167.0% |
| 2017 | 2.10x | ₩7.90 Billion | ₩16.58 Billion | ▼ -95.9% |
| 2016 | 51.55x | ₩243.66 Million | ₩12.56 Billion | ▲ +1692.4% |
| 2015 | 2.88x | ₩8.78 Billion | ₩25.26 Billion | — |